nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—Dacarbazine—melanoma	0.219	0.283	CbGbCtD
Ethosuximide—CYP3A4—Temozolomide—melanoma	0.158	0.205	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.101	0.131	CbGbCtD
Ethosuximide—CYP3A7—Docetaxel—melanoma	0.101	0.131	CbGbCtD
Ethosuximide—CYP3A4—Vemurafenib—melanoma	0.0864	0.112	CbGbCtD
Ethosuximide—CYP3A5—Docetaxel—melanoma	0.0761	0.0986	CbGbCtD
Ethosuximide—CYP3A4—Docetaxel—melanoma	0.0297	0.0384	CbGbCtD
Ethosuximide—Cerebration impaired—Temozolomide—melanoma	0.00414	0.0231	CcSEcCtD
Ethosuximide—Paranoia—Carmustine—melanoma	0.0037	0.0207	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Temozolomide—melanoma	0.00329	0.0184	CcSEcCtD
Ethosuximide—Aggression—Bleomycin—melanoma	0.00329	0.0184	CcSEcCtD
Ethosuximide—Eosinophilia—Vemurafenib—melanoma	0.00296	0.0165	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Docetaxel—melanoma	0.00293	0.0163	CcSEcCtD
Ethosuximide—Disturbance in attention—Temozolomide—melanoma	0.00281	0.0157	CcSEcCtD
Ethosuximide—Weight decreased—Vemurafenib—melanoma	0.00271	0.0151	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00264	0.0148	CcSEcCtD
Ethosuximide—Aplastic anaemia—Dactinomycin—melanoma	0.00253	0.0141	CcSEcCtD
Ethosuximide—Connective tissue disorder—Vemurafenib—melanoma	0.00235	0.0131	CcSEcCtD
Ethosuximide—Aplastic anaemia—Temozolomide—melanoma	0.00229	0.0128	CcSEcCtD
Ethosuximide—Erythema multiforme—Vemurafenib—melanoma	0.00226	0.0126	CcSEcCtD
Ethosuximide—Eye disorder—Vemurafenib—melanoma	0.00224	0.0125	CcSEcCtD
Ethosuximide—Mental disability—Carmustine—melanoma	0.00219	0.0122	CcSEcCtD
Ethosuximide—Mediastinal disorder—Vemurafenib—melanoma	0.00216	0.0121	CcSEcCtD
Ethosuximide—Rash erythematous—Docetaxel—melanoma	0.00212	0.0118	CcSEcCtD
Ethosuximide—Mental disability—Temozolomide—melanoma	0.00211	0.0118	CcSEcCtD
Ethosuximide—Malnutrition—Vemurafenib—melanoma	0.00208	0.0116	CcSEcCtD
Ethosuximide—Lethargy—Dactinomycin—melanoma	0.00199	0.0111	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00176	0.00984	CcSEcCtD
Ethosuximide—Pancytopenia—Bleomycin—melanoma	0.00172	0.00961	CcSEcCtD
Ethosuximide—Ataxia—Carmustine—melanoma	0.00172	0.00961	CcSEcCtD
Ethosuximide—Nervous system disorder—Vemurafenib—melanoma	0.00167	0.00932	CcSEcCtD
Ethosuximide—Ataxia—Temozolomide—melanoma	0.00166	0.00929	CcSEcCtD
Ethosuximide—Skin disorder—Vemurafenib—melanoma	0.00165	0.00923	CcSEcCtD
Ethosuximide—Weight decreased—Bleomycin—melanoma	0.00164	0.00916	CcSEcCtD
Ethosuximide—Pancytopenia—Dactinomycin—melanoma	0.0016	0.00897	CcSEcCtD
Ethosuximide—Breast disorder—Temozolomide—melanoma	0.0016	0.00893	CcSEcCtD
Ethosuximide—Haematuria—Bleomycin—melanoma	0.00154	0.00861	CcSEcCtD
Ethosuximide—Pancytopenia—Carmustine—melanoma	0.0015	0.00839	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00149	0.00835	CcSEcCtD
Ethosuximide—Decreased appetite—Vemurafenib—melanoma	0.00148	0.00826	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00147	0.0082	CcSEcCtD
Ethosuximide—Fatigue—Vemurafenib—melanoma	0.00147	0.00819	CcSEcCtD
Ethosuximide—Pancytopenia—Temozolomide—melanoma	0.00145	0.00811	CcSEcCtD
Ethosuximide—Agranulocytosis—Dactinomycin—melanoma	0.00141	0.00786	CcSEcCtD
Ethosuximide—Weight decreased—Temozolomide—melanoma	0.00138	0.00773	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00135	0.00755	CcSEcCtD
Ethosuximide—Erythema multiforme—Dactinomycin—melanoma	0.00128	0.00714	CcSEcCtD
Ethosuximide—Hypersensitivity—Vemurafenib—melanoma	0.00125	0.007	CcSEcCtD
Ethosuximide—Connective tissue disorder—Carmustine—melanoma	0.00124	0.00695	CcSEcCtD
Ethosuximide—Asthenia—Vemurafenib—melanoma	0.00122	0.00682	CcSEcCtD
Ethosuximide—Urinary tract disorder—Temozolomide—melanoma	0.00121	0.00675	CcSEcCtD
Ethosuximide—Connective tissue disorder—Temozolomide—melanoma	0.0012	0.00672	CcSEcCtD
Ethosuximide—Lethargy—Docetaxel—melanoma	0.0012	0.0067	CcSEcCtD
Ethosuximide—Urethral disorder—Temozolomide—melanoma	0.0012	0.0067	CcSEcCtD
Ethosuximide—Eye disorder—Carmustine—melanoma	0.00118	0.00661	CcSEcCtD
Ethosuximide—Diarrhoea—Vemurafenib—melanoma	0.00116	0.0065	CcSEcCtD
Ethosuximide—Erythema multiforme—Temozolomide—melanoma	0.00116	0.00646	CcSEcCtD
Ethosuximide—Eye disorder—Temozolomide—melanoma	0.00114	0.00639	CcSEcCtD
Ethosuximide—Leukopenia—Bleomycin—melanoma	0.00113	0.00631	CcSEcCtD
Ethosuximide—Dizziness—Vemurafenib—melanoma	0.00112	0.00628	CcSEcCtD
Ethosuximide—Mental disorder—Carmustine—melanoma	0.00111	0.0062	CcSEcCtD
Ethosuximide—Ataxia—Docetaxel—melanoma	0.00111	0.00618	CcSEcCtD
Ethosuximide—Immune system disorder—Temozolomide—melanoma	0.0011	0.00617	CcSEcCtD
Ethosuximide—Mediastinal disorder—Temozolomide—melanoma	0.0011	0.00616	CcSEcCtD
Ethosuximide—Malnutrition—Carmustine—melanoma	0.0011	0.00616	CcSEcCtD
Ethosuximide—Vomiting—Vemurafenib—melanoma	0.00108	0.00604	CcSEcCtD
Ethosuximide—Abdominal pain upper—Docetaxel—melanoma	0.00107	0.006	CcSEcCtD
Ethosuximide—Rash—Vemurafenib—melanoma	0.00107	0.00599	CcSEcCtD
Ethosuximide—Mental disorder—Temozolomide—melanoma	0.00107	0.00599	CcSEcCtD
Ethosuximide—Dermatitis—Vemurafenib—melanoma	0.00107	0.00599	CcSEcCtD
Ethosuximide—Headache—Vemurafenib—melanoma	0.00107	0.00595	CcSEcCtD
Ethosuximide—Malnutrition—Temozolomide—melanoma	0.00106	0.00595	CcSEcCtD
Ethosuximide—Breast disorder—Docetaxel—melanoma	0.00106	0.00594	CcSEcCtD
Ethosuximide—Cramp muscle—Docetaxel—melanoma	0.00106	0.00592	CcSEcCtD
Ethosuximide—Leukopenia—Dactinomycin—melanoma	0.00105	0.00589	CcSEcCtD
Ethosuximide—Agitation—Carmustine—melanoma	0.00101	0.00566	CcSEcCtD
Ethosuximide—Nausea—Vemurafenib—melanoma	0.00101	0.00564	CcSEcCtD
Ethosuximide—Leukopenia—Carmustine—melanoma	0.000986	0.00551	CcSEcCtD
Ethosuximide—Anorexia—Bleomycin—melanoma	0.000982	0.00549	CcSEcCtD
Ethosuximide—Agitation—Temozolomide—melanoma	0.000978	0.00547	CcSEcCtD
Ethosuximide—Pancytopenia—Docetaxel—melanoma	0.000965	0.00539	CcSEcCtD
Ethosuximide—Leukopenia—Temozolomide—melanoma	0.000953	0.00533	CcSEcCtD
Ethosuximide—Weight decreased—Docetaxel—melanoma	0.000919	0.00514	CcSEcCtD
Ethosuximide—Anorexia—Dactinomycin—melanoma	0.000916	0.00512	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0009	0.00503	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000898	0.00502	CcSEcCtD
Ethosuximide—Decreased appetite—Bleomycin—melanoma	0.000896	0.005	CcSEcCtD
Ethosuximide—Anorexia—Carmustine—melanoma	0.000857	0.00479	CcSEcCtD
Ethosuximide—Nervous system disorder—Temozolomide—melanoma	0.000852	0.00476	CcSEcCtD
Ethosuximide—Agranulocytosis—Docetaxel—melanoma	0.000846	0.00472	CcSEcCtD
Ethosuximide—Skin disorder—Temozolomide—melanoma	0.000844	0.00472	CcSEcCtD
Ethosuximide—Decreased appetite—Dactinomycin—melanoma	0.000835	0.00467	CcSEcCtD
Ethosuximide—Fatigue—Dactinomycin—melanoma	0.000828	0.00463	CcSEcCtD
Ethosuximide—Anorexia—Temozolomide—melanoma	0.000828	0.00463	CcSEcCtD
Ethosuximide—Urticaria—Bleomycin—melanoma	0.000818	0.00457	CcSEcCtD
Ethosuximide—Urinary tract disorder—Docetaxel—melanoma	0.000803	0.00449	CcSEcCtD
Ethosuximide—Somnolence—Carmustine—melanoma	0.000799	0.00447	CcSEcCtD
Ethosuximide—Connective tissue disorder—Docetaxel—melanoma	0.000799	0.00447	CcSEcCtD
Ethosuximide—Urethral disorder—Docetaxel—melanoma	0.000797	0.00446	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dactinomycin—melanoma	0.000786	0.00439	CcSEcCtD
Ethosuximide—Decreased appetite—Carmustine—melanoma	0.000782	0.00437	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Carmustine—melanoma	0.000776	0.00434	CcSEcCtD
Ethosuximide—Somnolence—Temozolomide—melanoma	0.000773	0.00432	CcSEcCtD
Ethosuximide—Erythema multiforme—Docetaxel—melanoma	0.000769	0.0043	CcSEcCtD
Ethosuximide—Eye disorder—Docetaxel—melanoma	0.00076	0.00425	CcSEcCtD
Ethosuximide—Abdominal pain—Dactinomycin—melanoma	0.00076	0.00424	CcSEcCtD
Ethosuximide—Hypersensitivity—Bleomycin—melanoma	0.000759	0.00424	CcSEcCtD
Ethosuximide—Decreased appetite—Temozolomide—melanoma	0.000755	0.00422	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Temozolomide—melanoma	0.00075	0.00419	CcSEcCtD
Ethosuximide—Fatigue—Temozolomide—melanoma	0.000749	0.00419	CcSEcCtD
Ethosuximide—Asthenia—Bleomycin—melanoma	0.000739	0.00413	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Carmustine—melanoma	0.000735	0.00411	CcSEcCtD
Ethosuximide—Immune system disorder—Docetaxel—melanoma	0.000735	0.00411	CcSEcCtD
Ethosuximide—Mediastinal disorder—Docetaxel—melanoma	0.000733	0.0041	CcSEcCtD
Ethosuximide—Mental disorder—Docetaxel—melanoma	0.000713	0.00398	CcSEcCtD
Ethosuximide—Abdominal pain—Carmustine—melanoma	0.000711	0.00397	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Temozolomide—melanoma	0.000711	0.00397	CcSEcCtD
Ethosuximide—Malnutrition—Docetaxel—melanoma	0.000708	0.00396	CcSEcCtD
Ethosuximide—Hypersensitivity—Dactinomycin—melanoma	0.000708	0.00396	CcSEcCtD
Ethosuximide—Urticaria—Temozolomide—melanoma	0.00069	0.00386	CcSEcCtD
Ethosuximide—Asthenia—Dactinomycin—melanoma	0.000689	0.00385	CcSEcCtD
Ethosuximide—Abdominal pain—Temozolomide—melanoma	0.000687	0.00384	CcSEcCtD
Ethosuximide—Muscle spasms—Docetaxel—melanoma	0.000681	0.0038	CcSEcCtD
Ethosuximide—Hypersensitivity—Carmustine—melanoma	0.000663	0.0037	CcSEcCtD
Ethosuximide—Diarrhoea—Dactinomycin—melanoma	0.000657	0.00367	CcSEcCtD
Ethosuximide—Vomiting—Bleomycin—melanoma	0.000655	0.00366	CcSEcCtD
Ethosuximide—Rash—Bleomycin—melanoma	0.00065	0.00363	CcSEcCtD
Ethosuximide—Dermatitis—Bleomycin—melanoma	0.000649	0.00363	CcSEcCtD
Ethosuximide—Asthenia—Carmustine—melanoma	0.000645	0.00361	CcSEcCtD
Ethosuximide—Hypersensitivity—Temozolomide—melanoma	0.00064	0.00358	CcSEcCtD
Ethosuximide—Leukopenia—Docetaxel—melanoma	0.000634	0.00354	CcSEcCtD
Ethosuximide—Asthenia—Temozolomide—melanoma	0.000623	0.00348	CcSEcCtD
Ethosuximide—Diarrhoea—Carmustine—melanoma	0.000615	0.00344	CcSEcCtD
Ethosuximide—Nausea—Bleomycin—melanoma	0.000612	0.00342	CcSEcCtD
Ethosuximide—Vomiting—Dactinomycin—melanoma	0.000611	0.00341	CcSEcCtD
Ethosuximide—Rash—Dactinomycin—melanoma	0.000606	0.00338	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000599	0.00335	CcSEcCtD
Ethosuximide—Dizziness—Carmustine—melanoma	0.000595	0.00332	CcSEcCtD
Ethosuximide—Diarrhoea—Temozolomide—melanoma	0.000595	0.00332	CcSEcCtD
Ethosuximide—Dizziness—Temozolomide—melanoma	0.000575	0.00321	CcSEcCtD
Ethosuximide—Vomiting—Carmustine—melanoma	0.000572	0.00319	CcSEcCtD
Ethosuximide—Nausea—Dactinomycin—melanoma	0.000571	0.00319	CcSEcCtD
Ethosuximide—Rash—Carmustine—melanoma	0.000567	0.00317	CcSEcCtD
Ethosuximide—Nervous system disorder—Docetaxel—melanoma	0.000567	0.00317	CcSEcCtD
Ethosuximide—Dermatitis—Carmustine—melanoma	0.000566	0.00317	CcSEcCtD
Ethosuximide—Headache—Carmustine—melanoma	0.000563	0.00315	CcSEcCtD
Ethosuximide—Skin disorder—Docetaxel—melanoma	0.000561	0.00314	CcSEcCtD
Ethosuximide—Vomiting—Temozolomide—melanoma	0.000553	0.00309	CcSEcCtD
Ethosuximide—Anorexia—Docetaxel—melanoma	0.000551	0.00308	CcSEcCtD
Ethosuximide—Rash—Temozolomide—melanoma	0.000548	0.00306	CcSEcCtD
Ethosuximide—Dermatitis—Temozolomide—melanoma	0.000547	0.00306	CcSEcCtD
Ethosuximide—Headache—Temozolomide—melanoma	0.000544	0.00304	CcSEcCtD
Ethosuximide—Nausea—Carmustine—melanoma	0.000534	0.00298	CcSEcCtD
Ethosuximide—Nausea—Temozolomide—melanoma	0.000516	0.00288	CcSEcCtD
Ethosuximide—Somnolence—Docetaxel—melanoma	0.000514	0.00287	CcSEcCtD
Ethosuximide—Decreased appetite—Docetaxel—melanoma	0.000502	0.00281	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Docetaxel—melanoma	0.000499	0.00279	CcSEcCtD
Ethosuximide—Fatigue—Docetaxel—melanoma	0.000498	0.00278	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Docetaxel—melanoma	0.000473	0.00264	CcSEcCtD
Ethosuximide—Abdominal pain—Docetaxel—melanoma	0.000457	0.00255	CcSEcCtD
Ethosuximide—Hypersensitivity—Docetaxel—melanoma	0.000426	0.00238	CcSEcCtD
Ethosuximide—Asthenia—Docetaxel—melanoma	0.000415	0.00232	CcSEcCtD
Ethosuximide—Diarrhoea—Docetaxel—melanoma	0.000395	0.00221	CcSEcCtD
Ethosuximide—Dizziness—Docetaxel—melanoma	0.000382	0.00214	CcSEcCtD
Ethosuximide—Vomiting—Docetaxel—melanoma	0.000367	0.00205	CcSEcCtD
Ethosuximide—Rash—Docetaxel—melanoma	0.000364	0.00204	CcSEcCtD
Ethosuximide—Dermatitis—Docetaxel—melanoma	0.000364	0.00203	CcSEcCtD
Ethosuximide—Headache—Docetaxel—melanoma	0.000362	0.00202	CcSEcCtD
Ethosuximide—Nausea—Docetaxel—melanoma	0.000343	0.00192	CcSEcCtD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP17A1—melanoma	0.00014	0.00283	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ITGAV—melanoma	0.000138	0.00278	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT3—melanoma	0.000138	0.00278	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—KDR—melanoma	0.000129	0.00261	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLCB4—melanoma	0.000127	0.00257	CbGpPWpGaD
Ethosuximide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000127	0.00256	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MET—melanoma	0.000127	0.00255	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ITGB1—melanoma	0.000125	0.00252	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000121	0.00244	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000121	0.00244	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC6A11—melanoma	0.00012	0.00242	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIP4K2A—melanoma	0.00012	0.00242	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP1B1—melanoma	0.00012	0.00241	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP1B1—melanoma	0.000118	0.00238	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MTAP—melanoma	0.000117	0.00235	CbGpPWpGaD
Ethosuximide—CYP2E1—Tryptophan metabolism—MDM2—melanoma	0.000116	0.00235	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000115	0.00233	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000111	0.00224	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000109	0.00221	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ITGB3—melanoma	0.000109	0.00219	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAP2K2—melanoma	0.000106	0.00214	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MMP2—melanoma	0.000106	0.00213	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MAP2K1—melanoma	0.000105	0.00213	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PHGDH—melanoma	0.000104	0.0021	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—LUM—melanoma	0.000104	0.0021	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP17A1—melanoma	0.000103	0.00208	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP17A1—melanoma	0.000103	0.00207	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HPSE—melanoma	0.000102	0.00206	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP17A1—melanoma	0.000101	0.00205	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP17A1—melanoma	0.000101	0.00204	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—RAC1—melanoma	0.000101	0.00203	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CUBN—melanoma	0.0001	0.00202	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SDHD—melanoma	9.66e-05	0.00195	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CSPG4—melanoma	9.66e-05	0.00195	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BSG—melanoma	9.66e-05	0.00195	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GPAM—melanoma	9.36e-05	0.00189	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	9.33e-05	0.00188	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—ERBB2—melanoma	9.25e-05	0.00187	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KDR—melanoma	9.23e-05	0.00186	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	9.21e-05	0.00186	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	9.1e-05	0.00184	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MET—melanoma	9.03e-05	0.00182	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—CDK4—melanoma	9.03e-05	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	8.99e-05	0.00181	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NOTCH1—melanoma	8.69e-05	0.00175	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP1B1—melanoma	8.66e-05	0.00175	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP1B1—melanoma	8.64e-05	0.00174	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP1B1—melanoma	8.54e-05	0.00172	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP1B1—melanoma	8.52e-05	0.00172	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	8.42e-05	0.0017	CbGpPWpGaD
Ethosuximide—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—melanoma	8.39e-05	0.00169	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARG—melanoma	8.2e-05	0.00165	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ACER3—melanoma	7.97e-05	0.00161	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PLA2G6—melanoma	7.96e-05	0.00161	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MMP9—melanoma	7.93e-05	0.0016	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.56e-05	0.00153	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP2—melanoma	7.53e-05	0.00152	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAP2K1—melanoma	7.52e-05	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—UGT2B10—melanoma	7.29e-05	0.00147	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—FGF2—melanoma	7.15e-05	0.00144	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—VCAN—melanoma	7.15e-05	0.00144	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—VEGFA—melanoma	7.12e-05	0.00144	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—NRAS—melanoma	7.04e-05	0.00142	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HS3ST5—melanoma	6.78e-05	0.00137	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MAPK3—melanoma	6.74e-05	0.00136	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ERBB2—melanoma	6.6e-05	0.00133	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MAPK1—melanoma	6.41e-05	0.00129	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—EGFR—melanoma	6.41e-05	0.00129	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—KRAS—melanoma	6.06e-05	0.00122	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP17A1—melanoma	6.03e-05	0.00122	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—CTNNB1—melanoma	5.77e-05	0.00116	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ACER3—melanoma	5.77e-05	0.00116	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ACER3—melanoma	5.76e-05	0.00116	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GNA11—melanoma	5.69e-05	0.00115	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP9—melanoma	5.66e-05	0.00114	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NFKB1—melanoma	5.6e-05	0.00113	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—FASN—melanoma	5.57e-05	0.00112	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC5A5—melanoma	5.48e-05	0.00111	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.39e-05	0.00109	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CD44—melanoma	5.29e-05	0.00107	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GNAQ—melanoma	5.29e-05	0.00107	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UGT2B10—melanoma	5.28e-05	0.00106	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UGT2B10—melanoma	5.27e-05	0.00106	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—HRAS—melanoma	5.15e-05	0.00104	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLCB4—melanoma	5.14e-05	0.00104	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—melanoma	5.08e-05	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP1B1—melanoma	5.08e-05	0.00102	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—STAT3—melanoma	5.03e-05	0.00102	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NRAS—melanoma	5.02e-05	0.00101	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—melanoma	4.93e-05	0.000994	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HS3ST5—melanoma	4.91e-05	0.00099	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HS3ST5—melanoma	4.9e-05	0.000988	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC6A11—melanoma	4.83e-05	0.000974	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIP4K2A—melanoma	4.83e-05	0.000974	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAPK3—melanoma	4.81e-05	0.00097	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.77e-05	0.000963	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.71e-05	0.00095	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTAP—melanoma	4.7e-05	0.000947	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAPK1—melanoma	4.58e-05	0.000923	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—EGFR—melanoma	4.57e-05	0.000923	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—melanoma	4.36e-05	0.000879	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KRAS—melanoma	4.32e-05	0.000872	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LUM—melanoma	4.19e-05	0.000844	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PHGDH—melanoma	4.19e-05	0.000844	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ABCB1—melanoma	4.18e-05	0.000843	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HPSE—melanoma	4.11e-05	0.000828	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CUBN—melanoma	4.03e-05	0.000813	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.02e-05	0.00081	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.96e-05	0.000799	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SDHD—melanoma	3.89e-05	0.000785	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CSPG4—melanoma	3.89e-05	0.000785	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BSG—melanoma	3.89e-05	0.000785	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PRKCA—melanoma	3.85e-05	0.000776	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ERCC2—melanoma	3.82e-05	0.00077	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GPAM—melanoma	3.77e-05	0.00076	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLCB4—melanoma	3.72e-05	0.00075	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLCB4—melanoma	3.71e-05	0.000749	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HRAS—melanoma	3.67e-05	0.000741	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—melanoma	3.52e-05	0.000709	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC6A11—melanoma	3.5e-05	0.000705	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIP4K2A—melanoma	3.5e-05	0.000705	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC6A11—melanoma	3.49e-05	0.000704	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIP4K2A—melanoma	3.49e-05	0.000704	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTAP—melanoma	3.4e-05	0.000686	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTAP—melanoma	3.4e-05	0.000685	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—melanoma	3.24e-05	0.000654	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PLA2G6—melanoma	3.2e-05	0.000646	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PHGDH—melanoma	3.03e-05	0.000612	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LUM—melanoma	3.03e-05	0.000612	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PHGDH—melanoma	3.03e-05	0.00061	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LUM—melanoma	3.03e-05	0.00061	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CG—melanoma	3.01e-05	0.000608	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HPSE—melanoma	2.97e-05	0.0006	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HPSE—melanoma	2.97e-05	0.000599	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CUBN—melanoma	2.92e-05	0.000589	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CUBN—melanoma	2.91e-05	0.000588	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—melanoma	2.91e-05	0.000587	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—VCAN—melanoma	2.88e-05	0.000581	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SDHD—melanoma	2.82e-05	0.000569	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CSPG4—melanoma	2.82e-05	0.000569	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BSG—melanoma	2.82e-05	0.000569	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SDHD—melanoma	2.81e-05	0.000567	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BSG—melanoma	2.81e-05	0.000567	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CSPG4—melanoma	2.81e-05	0.000567	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPAM—melanoma	2.73e-05	0.000551	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPAM—melanoma	2.72e-05	0.00055	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ACER3—melanoma	2.68e-05	0.00054	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CD—melanoma	2.65e-05	0.000534	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—melanoma	2.61e-05	0.000527	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UGT2B10—melanoma	2.45e-05	0.000494	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP17A1—melanoma	2.43e-05	0.00049	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PLA2G6—melanoma	2.32e-05	0.000468	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PLA2G6—melanoma	2.32e-05	0.000467	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—melanoma	2.31e-05	0.000466	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNA11—melanoma	2.29e-05	0.000463	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—melanoma	2.29e-05	0.000461	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HS3ST5—melanoma	2.28e-05	0.000459	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—FASN—melanoma	2.24e-05	0.000453	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC5A5—melanoma	2.21e-05	0.000445	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNAQ—melanoma	2.13e-05	0.00043	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CD44—melanoma	2.13e-05	0.00043	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—VCAN—melanoma	2.09e-05	0.000421	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—VCAN—melanoma	2.08e-05	0.00042	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1B1—melanoma	2.04e-05	0.000412	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—melanoma	2e-05	0.000402	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP17A1—melanoma	1.76e-05	0.000355	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP17A1—melanoma	1.76e-05	0.000354	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLCB4—melanoma	1.73e-05	0.000348	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ABCB1—melanoma	1.68e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNA11—melanoma	1.66e-05	0.000335	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNA11—melanoma	1.66e-05	0.000334	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—FASN—melanoma	1.63e-05	0.000328	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.62e-05	0.000327	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC6A11—melanoma	1.62e-05	0.000327	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—FASN—melanoma	1.62e-05	0.000327	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC5A5—melanoma	1.6e-05	0.000323	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC5A5—melanoma	1.6e-05	0.000322	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTAP—melanoma	1.58e-05	0.000318	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PRKCA—melanoma	1.55e-05	0.000313	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNAQ—melanoma	1.54e-05	0.000312	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CD44—melanoma	1.54e-05	0.000312	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNAQ—melanoma	1.54e-05	0.000311	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CD44—melanoma	1.54e-05	0.000311	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ERCC2—melanoma	1.54e-05	0.00031	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1B1—melanoma	1.48e-05	0.000299	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1B1—melanoma	1.48e-05	0.000298	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—melanoma	1.41e-05	0.000284	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LUM—melanoma	1.41e-05	0.000284	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PHGDH—melanoma	1.41e-05	0.000284	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HPSE—melanoma	1.38e-05	0.000278	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CUBN—melanoma	1.35e-05	0.000273	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SDHD—melanoma	1.31e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BSG—melanoma	1.31e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CSPG4—melanoma	1.31e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPAM—melanoma	1.27e-05	0.000256	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ABCB1—melanoma	1.22e-05	0.000246	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ABCB1—melanoma	1.22e-05	0.000245	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—melanoma	1.21e-05	0.000245	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—melanoma	1.17e-05	0.000236	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—melanoma	1.15e-05	0.000232	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PRKCA—melanoma	1.12e-05	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PRKCA—melanoma	1.12e-05	0.000226	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ERCC2—melanoma	1.11e-05	0.000225	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ERCC2—melanoma	1.11e-05	0.000224	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PLA2G6—melanoma	1.08e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—melanoma	1.07e-05	0.000215	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—melanoma	1.05e-05	0.000212	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—VCAN—melanoma	9.67e-06	0.000195	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—melanoma	9.3e-06	0.000188	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—melanoma	9.21e-06	0.000186	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—melanoma	8.79e-06	0.000177	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—melanoma	8.77e-06	0.000177	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—melanoma	8.48e-06	0.000171	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—melanoma	8.47e-06	0.000171	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP17A1—melanoma	8.16e-06	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—melanoma	8.04e-06	0.000162	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—melanoma	7.73e-06	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—melanoma	7.71e-06	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNA11—melanoma	7.71e-06	0.000155	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—melanoma	7.63e-06	0.000154	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—melanoma	7.61e-06	0.000154	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—FASN—melanoma	7.54e-06	0.000152	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC5A5—melanoma	7.42e-06	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNAQ—melanoma	7.17e-06	0.000145	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CD44—melanoma	7.17e-06	0.000145	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1B1—melanoma	6.87e-06	0.000139	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—melanoma	6.74e-06	0.000136	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—melanoma	6.72e-06	0.000136	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—melanoma	6.67e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—melanoma	6.66e-06	0.000134	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—melanoma	5.82e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—melanoma	5.81e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—melanoma	5.67e-06	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCB1—melanoma	5.66e-06	0.000114	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PRKCA—melanoma	5.21e-06	0.000105	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ERCC2—melanoma	5.16e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—melanoma	4.63e-06	9.34e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—melanoma	4.11e-06	8.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—melanoma	4.1e-06	8.27e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—melanoma	4.08e-06	8.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—melanoma	3.94e-06	7.94e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—melanoma	3.59e-06	7.23e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—melanoma	3.54e-06	7.14e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—melanoma	3.35e-06	6.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—melanoma	3.35e-06	6.75e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—melanoma	3.13e-06	6.3e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—melanoma	3.1e-06	6.25e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—melanoma	2.7e-06	5.45e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—melanoma	1.91e-06	3.84e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—melanoma	1.56e-06	3.14e-05	CbGpPWpGaD
